Parotis yerleşimli castleman hastalığına yaklaşım, bir olgu sunumu

Temel Bulgular & Veri:Bu makalede, parotis yerleşimli Castleman Hastalığı olan 45 yaşındaki hastanın tedavi yaklaşımı ve tedavi sonucu sunulmuştur.

💡

Sonuç & Katkı:Radyoterapi sonrası 12. ayda klinik ve radyolojik olarak rekürrens tespit edilmemiştir.

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Özet

Castleman Hastalığı nadir görülen, nedeni bilinmeyen, en sık mediastende saptanan, lenfoepitelial benign bir hastalıktır. Bu makalede, parotis yerleşimli Castleman Hastalığı olan 45 yaşındaki hastanın tedavi yaklaşımı ve tedavi sonucu sunulmuştur. Subtotal rezeksiyon uygulanan parotis yerleşimli kitleye adjuvan radyoterapi uygulanmıştır. Radyoterapi sonrası 12. ayda klinik ve radyolojik olarak rekürrens tespit edilmemiştir.

Abstract

Castleman’s Disease (CD) is a rare, benign lymphoepithelial disease of unknown cause, most commonly in the mediastinum. In this article; we report a new case of CD arising from the parotid gland. A 45 year-old male patient with parotid CD’s treatment approach and treatment result are presented. Subtotal parotidectomy was performed. After operation; adjuvan radiotherapy was performed. Clinically and radiologically no recurrence was noted during a follow up period of twelve months.

🔖

Bu Makaleye Atıf Yap

MAYADAĞLI, A., ÖZDEMİR, Z., AKSU, A., CEYLANER, B. B., EKEN, M., ÖZDEMİR, N. (2012). Parotis yerleşimli castleman hastalığına yaklaşım, bir olgu sunumu. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 46 - Sayı: 3, 153–156. https://ajindex.com/articles/364225

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

Castleman B, Towne VW, Case records of the Massachusetts General Hospital: Case No. 40231. N Engl J Med 1954; 250:1001-5
Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29: 670–683
Castleman B. Case report of the Massachusetts General Hospital. N Engl J Med 1954; 250: 26-30 4. Shin JH, Lee HK, Kim SY et al. Castleman’s disease in the retropharyngeal space: CT and MR imaging findings. AJNR 2000; 21:1337-9
Maslovsky I, Urıev L, Lugassy G. The heterogenity of Castleman’s disease: Report of five cases and review of the literature. Am J Med Sci 2000; 320:292-5
Rodrigo JP, Fernandez JA, Alvarez JC, Gomez J,Suarez C. Castleman’s disease restricted to the infratemporal fossa. The Journal of Laryngology and Otology. 110: 896-98, 1996 7. Penfold CN, Cottrell BJ, Talbot R. Neonatal giant lymph node hyperplasia (Castleman’s disease) presenting in the head and neck. British J Oral and Maxillofac Surg. 29:110-111, 1991
McCarty MJ, Vukelja SJ, Banks PM, Weiss RB: Angiofollicular lymph node hyperplasia (Castleman’s disease). Cancer Treat Rev 1995, 21(4):291-310
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956; 9: 822-830
Kimura H, Watanabe Y,Ohashi N,Kobayashi M et all. Immunologic study of the hyalin-vascular type of Castleman desease.Acta Otolaryngol 1993;504:146-148 11. Glazer M, Rao VM, Reiter D, McCue P. Isolated Castleman disease of the neck: MR findings. AJNR Am J Neuroradiol 1995; 16: 669-671 12. Shahidi H, Myers JL, Kvale PA. Castleman’ s disease. Mayo Clin Proc 1995; 70: 969-977 13. Minerva T, Franza R, Panico D, Pizzolante M, Cambo M. Castleman’s disease with diffuse cervical localisation: case report. Acta Otorhinolaryngol Ital 2004;24:234-8
Vries I, MS van Acht M, BJ Demeyere T, LM Lybeert M, Zoete J.P, Nieuwenhuijzen G. Neoadjuvant radiotherapy of primary irresectable unicentric Castleman’s disease: a case report and review of the literature. Radiation Oncology 2010; 5:7 15. Martı S, Pahissa A, Guardia J, Moragas A, Bacardi R. Multicentric Giant Follicular Lymph Node Hyperplasia Favorable Response to Radiotherapy. Cancer 1983; 51: 808-810 16. Pavlidis NA, Briassoulis E, Klouvas G, Bai M. Is Interferon-alpha anactive agent in Castleman’s disease? Ann Oncol 1992; 3: 85-86
Beck JT, Hsu SM, Wijdenes J, et al. Brief report: Alleviation of systemi